• Home
  • About Us
  • ICH S78 CiPA

Company Information Introducing NEXEL

ICH S7B CiPA

Make a Better Place

NEXEL Co., Ltd. was incorporated in 2012 as a spin-off from Korea University in Seoul, South Korea. NEXEL is a specialist in embryonic stem cell and induced pluripotent stem cell(iPSC) technology.

Our philosophy is to “Make a Better Place” by supporting innovative research around the globe through high quality iPSC-derived cell products and by developing our drug discovery pipelines to treat diseases.

NEXEL, Co., Ltd. aims to grow as a global leader in the bio-industry, embodied by its enthusiastic and passionate employees and corporate culture which supports creative innovation. Basing ourselves on state-of-the-art technology, our plan is to manufacture products of higher quality and improve the research environment of our valuable clients and collaborators. We also aim to directly improve the life quality of disease-affected patients by investing our resources into novel protein-based therapies targeting previously untreatable indications.
We at NEXEL truly believe our work will leave the world a better place than the one we found.